Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs United States Natural Gas Fund (UNG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alnylam Pharmaceuticals, Inc. vs United States Natural Gas Fund — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $303 (market cap $39.89B), while United States Natural Gas Fund trades at $10.43. Which is the better fit depends on your goals.
| ALNY | UNG | |
|---|---|---|
Market Cap | $39.89B | — |
Sector | Health | Commodities - Energy |
52-Week High | $491.22 | $16.90 |
52-Week Low | $278.09 | $10.15 |
Enterprise Value | $38.15B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALNY trades at $298.76, down 4.49% today, but maintains a bullish technical outlook with strong support at $290. The company reported robust revenue growth to $3.71 billion in 2025, turning profitable with net income of $313.75 million. Analyst consensus is strongly bullish with a $429.50 price target, supported by positive news on drug pipelines and AI partnerships.
Outlook remains positive driven by expanding product portfolio and strategic collaborations, though risks include clinical trial outcomes and high valuation multiples. Earnings beats in recent quarters reinforce growth trajectory, but dependence on key drug Amvuttra and competitive pressures warrant monitoring for sustained shareholder value.
UNG (United States Natural Gas Fund) trades at $10.60, down 2.12% amid bearish technical signals with 17 sell indicators versus 3 buy signals. The ETF faces headwinds from natural gas price volatility, though RSI levels near 30 suggest potential oversold conditions. Recent news highlights weather-driven demand fluctuations and structural challenges including contango effects that have historically eroded long-term returns.
Outlook remains cautious given the fund's tracking of futures contracts rather than company fundamentals. Key risks include weather dependency and LNG export volatility, while oversold technical conditions may offer short-term trading opportunities for risk-tolerant investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
Read more on ALNY →About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →
